FI86254C - Foerfarande foer framstaellning av insulinpreparat. - Google Patents

Foerfarande foer framstaellning av insulinpreparat. Download PDF

Info

Publication number
FI86254C
FI86254C FI874596A FI874596A FI86254C FI 86254 C FI86254 C FI 86254C FI 874596 A FI874596 A FI 874596A FI 874596 A FI874596 A FI 874596A FI 86254 C FI86254 C FI 86254C
Authority
FI
Finland
Prior art keywords
insulin
protamine
solution
zinc
magnesium
Prior art date
Application number
FI874596A
Other languages
English (en)
Finnish (fi)
Swedish (sv)
Other versions
FI86254B (fi
FI874596L (fi
FI874596A0 (fi
Inventor
Klavs Holger Joergensen
Original Assignee
Novo Nordisk As
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Priority claimed from DK503386A external-priority patent/DK503386D0/da
Priority claimed from DK356987A external-priority patent/DK356987D0/da
Application filed by Novo Nordisk As filed Critical Novo Nordisk As
Publication of FI874596A0 publication Critical patent/FI874596A0/fi
Publication of FI874596L publication Critical patent/FI874596L/fi
Publication of FI86254B publication Critical patent/FI86254B/fi
Application granted granted Critical
Publication of FI86254C publication Critical patent/FI86254C/fi

Links

Classifications

    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K38/00—Medicinal preparations containing peptides
    • A61K38/16—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof
    • A61K38/17—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof from animals; from humans
    • A61K38/22—Hormones
    • A61K38/28—Insulins
    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07K—PEPTIDES
    • C07K14/00—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof
    • C07K14/435—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof from animals; from humans
    • C07K14/575—Hormones
    • C07K14/62—Insulins

Landscapes

  • Health & Medical Sciences (AREA)
  • Chemical & Material Sciences (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Organic Chemistry (AREA)
  • Medicinal Chemistry (AREA)
  • Diabetes (AREA)
  • Gastroenterology & Hepatology (AREA)
  • Zoology (AREA)
  • Proteomics, Peptides & Aminoacids (AREA)
  • Endocrinology (AREA)
  • General Health & Medical Sciences (AREA)
  • Genetics & Genomics (AREA)
  • Biophysics (AREA)
  • Molecular Biology (AREA)
  • Biochemistry (AREA)
  • Toxicology (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Bioinformatics & Cheminformatics (AREA)
  • Immunology (AREA)
  • Engineering & Computer Science (AREA)
  • Epidemiology (AREA)
  • Animal Behavior & Ethology (AREA)
  • Public Health (AREA)
  • Veterinary Medicine (AREA)
  • Medicines That Contain Protein Lipid Enzymes And Other Medicines (AREA)
  • Peptides Or Proteins (AREA)
  • Medicinal Preparation (AREA)
FI874596A 1986-10-20 1987-10-19 Foerfarande foer framstaellning av insulinpreparat. FI86254C (fi)

Applications Claiming Priority (4)

Application Number Priority Date Filing Date Title
DK503386A DK503386D0 (da) 1986-10-20 1986-10-20 Peptidpraeparater
DK503386 1986-10-20
DK356987 1987-07-10
DK356987A DK356987D0 (forum.php) 1987-07-10 1987-07-10

Publications (4)

Publication Number Publication Date
FI874596A0 FI874596A0 (fi) 1987-10-19
FI874596L FI874596L (fi) 1988-04-21
FI86254B FI86254B (fi) 1992-04-30
FI86254C true FI86254C (fi) 1992-08-10

Family

ID=26067111

Family Applications (1)

Application Number Title Priority Date Filing Date
FI874596A FI86254C (fi) 1986-10-20 1987-10-19 Foerfarande foer framstaellning av insulinpreparat.

Country Status (18)

Country Link
US (1) US5070186A (forum.php)
EP (1) EP0265213B1 (forum.php)
KR (1) KR880004819A (forum.php)
CN (1) CN87107049A (forum.php)
AU (1) AU616381B2 (forum.php)
CA (1) CA1316819C (forum.php)
DE (1) DE3778287D1 (forum.php)
ES (1) ES2033871T3 (forum.php)
FI (1) FI86254C (forum.php)
GR (1) GR3004912T3 (forum.php)
HU (1) HU201475B (forum.php)
IE (1) IE60264B1 (forum.php)
IL (1) IL84203A (forum.php)
NO (1) NO170754C (forum.php)
NZ (1) NZ222214A (forum.php)
PH (1) PH23446A (forum.php)
PT (1) PT85949B (forum.php)
YU (1) YU46665B (forum.php)

Families Citing this family (34)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US5534488A (en) * 1993-08-13 1996-07-09 Eli Lilly And Company Insulin formulation
YU18596A (sh) * 1995-03-31 1998-07-10 Eli Lilly And Company Analogne formulacije monomernog insulina
DE69924232D1 (de) * 1998-01-09 2005-04-21 Novo Nordisk As Stabilisierte insulin-zubereitungen
US7678364B2 (en) 1999-08-25 2010-03-16 Alkermes, Inc. Particles for inhalation having sustained release properties
DE10114178A1 (de) * 2001-03-23 2002-10-10 Aventis Pharma Gmbh Zinkfreie und zinkarme Insulinzubereitungen mit verbesserter Stabilität
PL366787A1 (en) * 2001-08-27 2005-02-07 Novo Nordisk A/S A cartridge and a medical delivery system accommodating such a cartridge
EP2460530A3 (en) * 2002-12-31 2012-08-29 Althea Technologies, Inc. Human growth hormone crystals and methods for preparing them
NZ554885A (en) * 2002-12-31 2009-07-31 Altus Pharmaceuticals Inc Complexes of hgh crystals and protamine polymers
AU2006330833A1 (en) * 2005-12-23 2007-07-05 Altus Pharmaceuticals Inc. Compositions comprising polycation-complexed protein crystals and methods of treatment using them
JP5550338B2 (ja) 2006-07-31 2014-07-16 ノボ・ノルデイスク・エー／エス ペグ化持続型インスリン
AU2007298919C1 (en) 2006-09-22 2014-02-06 Novo Nordisk A/S Protease resistant insulin analogues
JP2010525033A (ja) * 2007-04-30 2010-07-22 ノボ・ノルデイスク・エー／エス 高濃縮のインスリン溶液及び組成物
CN101674812B (zh) 2007-04-30 2013-12-11 诺沃-诺迪斯克有限公司 干燥蛋白组合物的方法、干燥的蛋白组合物和包含干燥的蛋白的药物组合物
WO2009112583A2 (en) 2008-03-14 2009-09-17 Novo Nordisk A/S Protease-stabilized insulin analogues
CN102037008B (zh) 2008-03-18 2016-08-31 诺沃-诺迪斯克有限公司 蛋白酶稳定化的、酰化胰岛素类似物
NZ592283A (en) 2008-10-17 2012-09-28 Sanofi Aventis Deutschland Combination of an insulin and the GLP-1 agonist AVE0010
CN107308442B (zh) 2009-11-13 2022-10-18 赛诺菲-安万特德国有限公司 包含glp-1激动剂、胰岛素和甲硫氨酸的药物组合物
DK2498801T3 (en) 2009-11-13 2018-05-07 Sanofi Aventis Deutschland PHARMACEUTICAL COMPOSITION INCLUDING desPro36Exendin-4 (1-39) -Lys6-NH2 AND METHIONIN
CN101912600B (zh) * 2010-01-11 2014-01-29 杨国汉 改善胰岛素在溶液中稳定性的方法
US8637458B2 (en) * 2010-05-12 2014-01-28 Biodel Inc. Insulin with a stable basal release profile
AU2011202239C1 (en) 2010-05-19 2017-03-16 Sanofi Long-acting formulations of insulins
BR112013004756B1 (pt) 2010-08-30 2020-04-28 Sanofi Aventis Deutschland uso de ave0010 para a fabricação de um medicamento para o tratamento da diabetes melito tipo 2
US9821032B2 (en) 2011-05-13 2017-11-21 Sanofi-Aventis Deutschland Gmbh Pharmaceutical combination for improving glycemic control as add-on therapy to basal insulin
JP6367115B2 (ja) 2011-08-29 2018-08-01 サノフィ−アベンティス・ドイチュラント・ゲゼルシャフト・ミット・ベシュレンクテル・ハフツング ２型糖尿病患者の血糖コントロールに使用する組合せ医薬
TWI559929B (en) 2011-09-01 2016-12-01 Sanofi Aventis Deutschland Pharmaceutical composition for use in the treatment of a neurodegenerative disease
US9481721B2 (en) 2012-04-11 2016-11-01 Novo Nordisk A/S Insulin formulations
US9399065B2 (en) 2012-04-16 2016-07-26 Biodel Inc. Magnesium compositions for modulating the pharmacokinetics and injection site pain of insulin
US9381247B2 (en) * 2012-04-16 2016-07-05 Biodel Inc. Magnesium compositions for modulating the pharmacokinetics and pharmacodynamics of insulin and insulin analogs, and injection site pain
CA2907848A1 (en) 2013-04-03 2014-10-09 Sanofi Treatment of diabetes mellitus by long-acting formulations of insulins
US9896496B2 (en) 2013-10-07 2018-02-20 Novo Nordisk A/S Derivative of an insulin analogue
US9950039B2 (en) 2014-12-12 2018-04-24 Sanofi-Aventis Deutschland Gmbh Insulin glargine/lixisenatide fixed ratio formulation
TWI748945B (zh) 2015-03-13 2021-12-11 德商賽諾菲阿凡提斯德意志有限公司 第２型糖尿病病患治療
TW201705975A (zh) 2015-03-18 2017-02-16 賽諾菲阿凡提斯德意志有限公司 第２型糖尿病病患之治療
EP3554534B1 (en) 2016-12-16 2021-06-23 Novo Nordisk A/S Insulin containing pharmaceutical compositions

Family Cites Families (15)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US2076082A (en) * 1935-04-08 1937-04-06 Nordisk Insulinlab Therapeutic product and process
US2179384A (en) * 1937-04-05 1939-11-07 Univ Alberta Therapeutic composition and process of making it
US2190134A (en) * 1939-06-09 1940-02-13 Norton Co Grinding machine
US2538018A (en) * 1944-04-04 1951-01-16 Nordisk Insulinlab Crystalline product of insulin and alkaline protein and process of making it
US2474729A (en) * 1945-01-03 1949-06-28 Rhone Poulenc Sa Insulin preparations
US2801953A (en) * 1952-02-28 1957-08-06 Hoechst Ag Process of preparing crystallized insulin preparations
US3102077A (en) * 1953-08-19 1963-08-27 Christensen Henry Marinus Preparation of insulin containing 2.75 to 8 percent zinc content
DK98342C (da) * 1959-06-16 1964-03-31 Henry Marinus Dr Christensen Fremgangsmåde til fremstilling af et insulinpræparat til peroral applikation.
US3868358A (en) * 1971-04-30 1975-02-25 Lilly Co Eli Protamine-insulin product
GB1426061A (en) * 1972-12-28 1976-02-25 Ici Ltd Polypeptides
US3856771A (en) * 1973-07-16 1974-12-24 Lilly Co Eli Process for manufacturing alkali metal or ammonium insulin
US4196196A (en) * 1978-06-19 1980-04-01 Tiholiz Ivan C Divalen/monovalent bipolar cation therapy for enhancement of tissue perfusion and reperfusion in disease states
AU550068B2 (en) * 1981-03-10 1986-02-27 Novo Nordisk A/S Zinc insulin stabilized with calcium or magnesium salts
US4839341A (en) * 1984-05-29 1989-06-13 Eli Lilly And Company Stabilized insulin formulations
US4764592A (en) * 1987-04-23 1988-08-16 Eli Lilly And Company Crystalline human proinsulin and process for its production

Also Published As

Publication number Publication date
EP0265213B1 (en) 1992-04-15
NO874347D0 (no) 1987-10-19
FI86254B (fi) 1992-04-30
FI874596L (fi) 1988-04-21
AU616381B2 (en) 1991-10-31
EP0265213A2 (en) 1988-04-27
US5070186A (en) 1991-12-03
PT85949B (pt) 1990-07-31
NZ222214A (en) 1989-11-28
IE872799L (en) 1988-04-20
NO170754B (no) 1992-08-24
PT85949A (en) 1987-11-01
IL84203A (en) 1993-04-04
AU7990787A (en) 1988-04-21
HU201475B (en) 1990-11-28
CA1316819C (en) 1993-04-27
ES2033871T3 (es) 1993-04-01
CN87107049A (zh) 1988-07-06
YU191887A (en) 1989-04-30
YU46665B (sh) 1994-01-20
NO874347L (no) 1988-04-21
FI874596A0 (fi) 1987-10-19
IE60264B1 (en) 1994-06-29
EP0265213A3 (en) 1988-11-09
DE3778287D1 (de) 1992-05-21
GR3004912T3 (forum.php) 1993-04-28
HUT46232A (en) 1988-10-28
KR880004819A (ko) 1988-06-27
PH23446A (en) 1989-08-07
NO170754C (no) 1992-12-02

Similar Documents

Publication Publication Date Title
FI86254C (fi) Foerfarande foer framstaellning av insulinpreparat.
EP0506792B1 (en) Insulin preparations containing nicotinic acid or nicotinamide
US5177058A (en) Pharmaceutical formulation for the treatment of diabetes mellitus
RU2506945C2 (ru) Лекарственные формы инсулина, обладающие быстрым усвоением
US4608364A (en) Pharmaceutical agent for the treatment of diabetes mellitus
KR100546225B1 (ko) 신속한 작용개시를 나타내는 인슐린 유도체
AU612141B2 (en) Novel insulin derivatives
EP0194864B1 (en) Novel peptides
AU720484B2 (en) Insulin preparations containing NaCl
KR20120047226A (ko) 인슐린, 니코틴아미드 및 아미노산을 포함하는 제제
WO1995005848A1 (en) Protracted glp-1
EP0938902B1 (en) Pharmaceutical composition containing human growth hormone
JP2003526599A (ja) 安定化水溶性ペプチド溶液
JP3131215B2 (ja) 新規インスリン誘導体
CA2203396A1 (en) A storage stable water solution for infusion containing a thrombin inhibitor
JPS63179831A (ja) インシュリン製剤
DK157901B (da) Insulinpraeparat til parenteral administration indeholdende magnesiumioner

Legal Events

Date Code Title Description
MM Patent lapsed
MM Patent lapsed

Owner name: NOVO NORDISK A/S